Mesenchymal progenitor cells

BIOLOGICAL3 trials

Sponsors

Shanghai AbelZeta Ltd.

Conditions

Knee OsteoarthritisOsteoarthritis

Phase 1

Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis

CompletedNCT02641860

Shanghai AbelZeta Ltd.Osteoarthritis

Start: 2015-12-31End: 2018-03-31Updated: 2018-09-13

Phase 2

Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis

CompletedNCT02162693

Shanghai AbelZeta Ltd.Knee Osteoarthritis

Start: 2013-11-30End: 2016-11-30Updated: 2017-11-17

Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis

CompletedNCT04208646

Shanghai AbelZeta Ltd.Knee Osteoarthritis

Start: 2020-05-16End: 2023-07-31Updated: 2023-08-01

Related Papers

Multi-compositional MRI evaluation of repair cartilage in knee osteoarthritis with treatment of allogeneic human adipose-derived mesenchymal progenitor cells.

2019-10-2152 citations

Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial.

2019-05-21177 citations